Fig. 4From: Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway Cordycepin increases osteosarcoma cell sensitivity to cisplatin by activating the AMPK signaling pathway and suppressing the AKT signaling pathway. a, b Western blotting analysis showing the protein expression levels of p-AMPK, p-AKT, p-mTOR, and p-p70S6K in U2OS and 143B osteosarcoma cells following a treatment with cordycepin (200 µM), cisplatin (1 µM), or their combination for 48 hBack to article page